FDAnews
www.fdanews.com/articles/81823-watson-pharmaceuticals-named-exclusive-distributor-of-authorized-generic-oxycontin-r-tablets

WATSON PHARMACEUTICALS NAMED EXCLUSIVE DISTRIBUTOR OF AUTHORIZED GENERIC OXYCONTIN(R) TABLETS

October 20, 2005

Watson Pharmaceuticals, Inc. (NYSE: WPI -- News), a leading specialty pharmaceutical company, announced today that, under a supply agreement with Purdue Pharma L.P., Watson has been appointed as the exclusive distributor of authorized generic oxycodone HCl controlled-release tablets C-II in 10, 20, 40 and 80 mg dosage strengths. Oxycodone HCl is the generic version of Purdue's OxyContin® (C-II) Tablets, a narcotic analgesic indicated for the treatment of moderate to severe pain for patients in need of a continuous round-the-clock analgesic for an extended period of time.

Yahoo News (http://biz.yahoo.com/prnews/051018/latu140.html?.v=13)